CARDIAC TOXICITY
Clinical trials for CARDIAC TOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIAC TOXICITY trials appear
Sign up with your email to follow new studies for CARDIAC TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart-Saving pill for cancer patients?
Disease control Recruiting nowThis study is testing whether adding cholesterol-lowering statin drugs can protect the heart in patients receiving targeted therapy for early-stage HER2-positive breast cancer. Researchers want to see if statins reduce treatment delays or early stops caused by heart side effects.…
Matched conditions: CARDIAC TOXICITY
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
Cancer survivors ask: can we stop the heart pills?
Disease control Recruiting nowThis study aims to find out if cancer survivors can safely stop taking heart failure medications after their heart function has returned to normal following cancer treatment side effects. Researchers will compare two groups: one that continues medications and one that stops them,…
Matched conditions: CARDIAC TOXICITY
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC